Interrelation of Blood Microrheological Parameters Measured by Optical Methods and Whole Blood Viscosity in Patients Suffering from Blood Disorders: a Pilot Study
Petr B. Ermolinskiy
(Login required)
M.V. Lomonosov Moscow State University, Russian Federation
Paper #9072 received 29 Fen 2024; revised manuscript received 28 Mar 2024; accepted for publication 9 Apr 2024; published online 1 Jun 2024.
DOI: 10.18287/JBPE24.10.020306
Abstract
The perfusion of tissues and blood flux strongly depend on several interdependent parameters, such as viscosity of blood, red blood cell aggregation and red blood cell deformation. In case of many blood disorders these parameters are altered. This pilot study aimed to investigate the relationship between whole blood viscosity and microrheological parameters in patients with essential thrombocythemia (ET), as well as to compare microrheological parameters in patients with ET, erythrocytosis and spherocytosis. Blood viscosity measurements were performed using a rotational viscometer, while microrheological parameters were assessed through laser aggregometry and laser diffractometry techniques. The findings revealed novel data of the correlation between whole blood viscosity and microrheological parameters of patients with ET. Overall, this study provides valuable preliminary evidence on the relationship between whole blood viscosity and microrheological parameters in the context of blood disorders.
Keywords
Full Text:
PDFReferences
1. E. Nader, S. Skinner, M. Romana, R. Fort, N. Lemonne, N. Guillot, A. Gauthier, S. Antoine-Jonville, C. Renoux, M.-D. Hardy-Dessources, E. Stauffer, P. Joly, Y. Bertrand, and P. Connes, “Blood rheology: key parameters, impact on blood flow, role in sickle cell disease and effects of exercise,” Frontiers in Physiology 10, 1329 (2019).
2. S. Chien, “Determinants of blood viscosity and red cell deformability,” Scandinavian Journal of Clinical and Laboratory Investigation 41(156), 7–12 (1981).
3. O. Baskurt, H. Meiselman, “Blood rheology and hemodynamics,” Seminars in Thrombosis and Hemostasis 29(5), 435–450 (2003).
4. O. Baskurt, B. Neu, and H. J. Meiselman, Red Blood Cell Aggregation, 1st ed., CRC Press, Boca Raton, FL, USA (2011). ISBN: 978-0-367-38231-5.
5. H. J. Meiselman, “Red blood cell aggregation: 45 years being curious,” Biorheology 46(1), 1–19 (2009).
6. A. Maslianitsyna, P. Ermolinskiy, A. Lugovtsov, A. Pigurenko, M. Sasonko, Y. Gurfinkel, and A. Priezzhev, “Multimodal Diagnostics of Microrheologic Alterations in Blood of Coronary Heart Disease and Diabetic Patients,” Diagnostics 11(1), 76 (2021).
7. Y. A. Sheremet’ev, A. N. Popovicheva, M. M. Rogozin, and G. Ya. Levin, “Red blood cell aggregation, disaggregation and aggregate morphology in autologous plasma and serum in diabetic foot disease,” Clinical Hemorheology and Microcirculation 72(3), 221–227 (2019).
8. G. D. O. Lowe, A. J. Lee, A. Rumley, J. F. Price, and F. G. R. Fowkes, “Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study,” British Journal of Haematology 96(1), 168–173 (1997).
9. T. Gori, P. S. Wild, R. Schnabel, A. Schulz, N. Pfeiffer, M. Blettner, M. E. Beutel, S. Forconi, F. Jung, K. J. Lackner, S. Blankenberg, and T. Münzel, “The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: cross-sectional analysis from the Gutenberg Health Study,” Therapeutic Advances in Cardiovascular Disease 9(6), 354–365 (2015).
10. B. Porro, E. Conte, A. Zaninoni, P. Bianchi, F. Veglia, S. Barbieri, S. Fiorelli, S. Eligini, A. Di Minno, S. Mushtaq, E. Tremoli, V. Cavalca, and D. Andreini, “Red Blood Cell Morphodynamics: A New Potential Marker in High-Risk Patients,” Frontiers in Physiology 11, 603633 (2021).
11. S. Fowlkes, C. Murray, A. Fulford, T. De Gelder, and N. Siddiq, “Myeloproliferative neoplasms (MPNs) – Part 1: An overview of the diagnosis and treatment of the “classical” MPNs,” Canadian Oncology Nursing Journal 28(4), 262–268 (2018).
12. S. Prakash, D. A. Arber, C. Bueso-Ramos, R. P. Hasserjian, and A. Orazi, “Advances in myelodysplastic/myeloproliferative neoplasms,” Virchows Archiv 482(1), 69–83 (2023).
13. A. Tefferi, A. Pardanani, “Essential thrombocythemia,” New England Journal of Medicine 381(22), 2135–2144 (2019).
14. J. W. Harvey, “Evaluation of Erythrocytes,” Chapter 4 in Veterinary Hematology, Elsevier, 49–121 (2012).
15. A. Iolascon, R. A. Avvisati, and C. Piscopo, “Hereditary spherocytosis,” Transfusion Clinique et Biologique 17(3), 138–142 (2010).
16. A. Tefferi, “Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management,” American Journal of Hematology 87(3), 284–293 (2012).
17. H. Reikvam, R. V Tiu, “Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera,” Leukemia 26(4), 563–571 (2012).
18. Y. Parashar, R. Kushwaha, A. Kumar, K. Agarwal, U. Singh, M. Jain, S. Verma, and A. Tripathi, “Haemostatic profile in patients of myeloproliferative neoplasms-a tertiary care centre experience,” Journal of Clinical and Diagnostic Research 10(11), EC01–EC04 (2016).
19. A. R. Moliterno, Y. Z. Ginzburg, and R. Hoffman, “Clinical insights into the origins of thrombosis in myeloproliferative neoplasms,” Blood 137(9), 1145–1153 (2021).
20. A. Schafer, “Bleeding and thrombosis in the myeloproliferative disorders,” Blood 64(1), 1–12 (1984).
21. L. Repsold, A. M. Joubert, “platelet function, role in thrombosis, inflammation, and consequences in chronic myeloproliferative disorders,” Cells 10(11), 3034 (2021).
22. S. Avram, A. Lupu, S. Angelescu, N. Olteanu, and D. Mut-Popescu, “Abnormalities of platelet aggregation in chronic myeloproliferative disorders,” Journal of Cellular and Molecular Medicine 5(1), 79–87 (2001).
23. M. W. Saif, U. Khan, and B. R. Greenberg, “Cardiac complications of myeloproliferative disorders,” Resident and Staff Physician 47(8), 32–38 (2001).
24. P. I. Kuznetsova, A. A. Raskurazhev, A. A. Shabalina, A. L. Melikhyan, I. N. Subortseva, and M. M. Tanashyan, “Red Blood Cell Morphodynamics in Patients with Polycythemia Vera and Stroke,” International Journal of Molecular Sciences 23(4), 2247 (2022).
25. D. W. Shin, J.-Y. Gu, J. S. Kim, J.-S. Jung, D.-Y. Shin, Y. Koh, I. Kim, and H. K. Kim, “Increased plasma viscosity in plasma cell dyscrasia and whole blood viscosity in polycythemia vera,” Clinical Hemorheology and Microcirculation 70(1), 59–67 (2018).
26. R. Huisjes, A. Makhro, E. Llaudet-Planas, L. Hertz, P. Petkova-Kirova, L. P. Verhagen, S. Pignatelli, M. A. E. Rab, R. M. Schiffelers, E. Seiler, W. W. van Solinge, J.-Ll. V. Corrons, L. Kaestner, M. Mañú-Pereira, A. Bogdanova, and R. van Wijk, “Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis,” Haematologica 105(2), 338–347 (2020).
27. M. Uyuklu, M. Cengiz, P. Ulker, T. Hever, J. Tripette, P. Connes, N. Nemeth, H. J. Meiselman, and O. K. Baskurt, “Effects of storage duration and temperature of human blood on red cell deformability and aggregation,” Clinical Hemorheology and Microcirculation 41(4), 269–278 (2009).
28. Y.-I. Cho, D. J. Cho, “Hemorheology and microvascular disorders,” Korean Circulation Journal 41(6), 287 (2011).
29. I. M. Krieger, T. J. Dougherty, “A mechanism for non-newtonian flow in suspensions of rigid spheres,” Transactions of the Society of Rheology 3(1), 137–152 (1959).
30. C. Trejo-Soto, A. Hernández-Machado, “Normalization of blood viscosity according to the hematocrit and the shear rate,” Micromachines 13(3), 357 (2022).
31. H. Stark, S. Schuster, “Comparison of various approaches to calculating the optimal hematocrit in vertebrates,” Journal of Applied Physiology 113(3), 355–367 (2012).
32. S. Shin, Y. Yang, and J.-S. Suh, “Measurement of erythrocyte aggregation in a microchip stirring system by light transmission,” Clinical Hemorheology and Microcirculation 41(3), 197–207 (2009).
33. A. N. Semenov, A. E. Lugovtsov, E. A. Shirshin, B. P. Yakimov, P. B. Ermolinskiy, P. Y. Bikmulina, D. S. Kudryavtsev, P. S. Timashev, A. V. Muravyov, C. Wagner, S. Shin, and A. V. Priezzhev, “Assessment of Fibrinogen macromolecules interaction with red blood cells membrane by means of laser aggregometry, flow cytometry, and optical tweezers combined with microfluidics,” Biomolecules 10(10), 1448 (2020).
34. V. Lopatin, A. Priezzhev, A. Aponasenko, N. Shepelevich, V. Lopatin, P. Pozhilenkova, and I. Prostakova, Light Scattering Methods in the Analysis of Disperse Biological Media, 1st ed., Fizmatlit, Moscow (2004). [In Russian]. ISBN: 5-9221-0547-7.
35. A. E. Lugovtsov, Y. I. Gurfinkel, P. B. Ermolinskiy, A. I. Maslyanitsina, L. I. Dyachuk, and A. V. Priezzhev, “Optical assessment of alterations of microrheologic and microcirculation parameters in cardiovascular diseases,” Biomedical Optics Express 10(8), 3974−3986 (2019).
36. A. Semenov, A. Lugovtsov, P. Ermolinskiy, K. Lee, and A. Priezzhev, “Problems of Red Blood Cell Aggregation and Deformation Assessed by Laser Tweezers, Diffuse Light Scattering and Laser Diffractometry,” Photonics 9(4), 238 (2022).
37. O. K. Baskurt, M. R. Hardeman, M. Uyuklu, P. Ulker, M. Cengiz, N. Nemeth, S. Shin, T. Alexy, and H. J. Meiselman, “Comparison of three commercially available ektacytometers with different shearing geometries,” Biorheology 46(3), 251–264 (2009).
38. N. N. Firsov, A. V. Priezzhev, N. V. Klimova, and A. Yu. Tyurina, “Fundamental laws of the deformational behavior of erythrocytes in shear flow,” Journal of Engineering Physics and Thermophysics 79(1), 118–124 (2006).
39. S. Shin, Y.-H. Ku, J.-X. Ho, Y.-K. Kim, J.-S. Suh, and M. Singh, “Progressive impairment of erythrocyte deformability as indicator of microangiopathy in type 2 diabetes mellitus,” Clinical Hemorheology and Microcirculation 36(3), 253–261 (2007).
40. S. Shin, Y. Ku, “Hemorheology and clinical application : association of impairment of red blood cell deformability with diabetic nephropathy,” Korea-Australia Rheology Journal 17(3), 117–123 (2005).
Сontact
34 Moskovskoe shosse, Samara, 443086, Russian Federation
Email: j-bpe@ssau.ru
Phone: +7-846-267-4550
© 2014-2025 J-BPE